FindTrial
Sign In

Effects of 940 nm laser application on the control of mouth opening difficulty, swelling, pain and sensitivity after jaw surgery.

Effects of 940 nm laser photobiomodulation therapy on the control of trismus, edema, pain and paraesthesia after orthognathic surgery. Randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4m3mx7
Enrollment
Unknown
Registered
2020-01-10
Start date
2019-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dentofacial anomaly, unspecified

Interventions

Ten subjects will be randomized in the 940 nm laser group and 10 subjects in the control group (placebo laser therapy). Laser group volunteers will retain 24- and 48-hour postoperative photobiomodulat
Procedure/surgery
Radiation
Q10.030.010

Sponsors

Faculdade de Odontologia da Universidade de São Paulo
Lead Sponsor
Hospital Santa Catarina
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Individuals indicated to undergo bimaxillary orthognathic surgery with genioplasty; removal of third molars at least 6 months before surgery; regardless of gender and race; age group above 18 years; Signature of the Informed Consent Form (ICF).

Exclusion criteria

Exclusion criteria: Individuals submitted to monomaxillary surgery will be excluded; patients under 18 years of age; individuals with temporomandibular joint dysfunction; rupture of the inferior alveolar nerve during the surgical procedure; undesirable fractures; mandibular surgery with execution time above 2:30 h; deficient mandibular fixation; allergy to standardized anti-inflammatory drugs; postoperative infection; individuals who did not cooperate with PBMT therapy.

Design outcomes

Primary

MeasureTime frame
To evaluate whether 940 nm laser photobiomodulation therapy in the postoperative period of orthognathic surgery will bring benefits to the patient in the postoperative period.—

Secondary

MeasureTime frame
The 940 nm laser photobiomodulation therapy in the postoperative period of orthognathic surgery is expected to decrease the amount of edema in the postoperative period.;The 940 nm laser photobiomodulation therapy in the postoperative period of orthognathic surgery is expected to decrease the amount of pain in the postoperative period.;The 940 nm laser photobiomodulation therapy in the postoperative period of orthognathic surgery is expected to decrease the amount of patient paraesthesia in the postoperative period.;The 940 nm laser photobiomodulation therapy in the postoperative period of orthognathic surgery is expected to decrease the amount of patient trismus in the postoperative period.—

Countries

Brazil

Contacts

Public ContactRicardo Davila

Faculdade de Odontologia da Universidade de São Paulo

r.pimentadavila@gmail.com+55(11)98299-9494

Outcome results

None listed

Source: REBEC (via WHO ICTRP)